The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Pontifax Late Stage Gp Ltd. since 2020.
The trader's CIK number is 1793770.
At the time of the last reporting, Pontifax Late Stage Gp Ltd. was the 10% Owner of Keros Therapeutics, Inc.. (stock ticker symbol KROS).
Also see all insider trading activities at Keros Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | KROS | 617,499 | $15,999,984 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-11-17 | KROS | Buy | 60,000 | 50.00 | 3,000,000 |
| 2020-11-17 | KROS | Buy | 60,000 | 50.00 | 3,000,000 |
| 2020-11-17 | KROS | Buy | 60,000 | 50.00 | 3,000,000 |
| 2020-04-13 | KROS | Buy | 437,499 | 16.00 | 6,999,984 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pontifax Late Stage Gp Ltd. (10% Owner of Keros Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.